Trademark Search  /  PNEOO

PNEOO

● Live · Registered

U.S. federal trademark · Serial No. 79407300 · Reg. No. 8226523

Mark
PNEOO
Status
Registered
Serial Number
79407300
Registration No.
8226523
Filing Date
August 8, 2024
Registration Date
April 28, 2026
Class(es)
Class 001, Class 005, Class 040, Class 042

Owners

PNEOO B.V.
26 · BE
PNEOO B.V.
26 · BE
PNEOO B.V.
26 · BE

Goods & Services

Medical research services for the treatment of various medical disorders, cancer, pulmonary diseases, respiratory diseases, and infectious diseases; Scientific laboratory services; scientific research for medical purposes in the area of diseases; scientific research in the field of genetics and genetic engineering; genetic research for scientific research purposes; genetic mapping for scientific purposes; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; providing scientific research information in the field of medical disorders and their treatment; biotechnological research relating to enzymatic synthesis; toxicity testing for scientific research purposes; toxicity analysis for scientific research purposes; software as a service (SaaS) featuring artificial intelligence software for use in database management relating to the medical field; software as a service (SaaS) featuring software for use in data base management relating to the medical field; all of the aforementioned services solely related to respiratory and pulmonary diseases, including lung cancer

Medical, biological, and pharmaceutical preparations for the treatment of pulmonary diseases; veterinary preparations for pets, cattle, livestock for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; medical, biological, and pharmaceutical preparations for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes, the foregoing solely related to respiratory and pulmonary diseases, including lung cancer; pharmaceutical compounds being a component in pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases of the respiratory system; diagnostic preparations for medical purposes, the foregoing solely related to respiratory and pulmonary diseases, including lung cancer; chemical diagnostic reagents for medical use, the foregoing solely related to respiratory and pulmonary diseases, including lung cancer

Biological preparations for use in cell cultures, other than for medical or veterinary purposes, for boosting cells in the immune system for improved therapies; biological preparations for use in cell cultures, in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents in the nature of complexes of molecules for scientific research and for clinical and industrial use; proteins for use in scientific research; regulatory proteins in raw material for scientific research; the aforementioned goods solely related to respiratory and pulmonary diseases, including lung cancer

Provision of information, advice and consultancy services in the fields of cell therapy, gene editing, protein replacement, and antibodies, the aforementioned services solely related to respiratory and pulmonary diseases, including lung cancer

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "PNEOO" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.